US FDA Would Get Mandatory Recall Authority For Drugs Under House Funding Bill

 
• By Derrick Gingery
In a voice vote on 9 July, the US House Appropriations Committee approved an amendment giving the FDA the power to mandate drug recalls. Industry lobbyists had blocked an effort to give the agency the authority in 2012. • Source: screenshot

More from Manufacturing

More from Compliance